Know All Investments completed the following investment transactions during 2018: (Click the icon to view the transactions.) Requirements 1. Journalize the entries for 2018. Explanations are not required. 2. What account(s) and amount(s), if any, would be reported on Know All's income statement for the year ended December 31, 2018? Requirement 1. Journalize the entries for 2018. Explanations are not required. (Record debits first, then credits. Exclude explanations from journal entries. If no entry is required, select "No entry required" on the first line of the Accounts column and leave the remaining cells blank.) Jan. 14: Purchased 700 shares of Phyflexon stock, paying $51 per share. The investment represents 4% ownership in Phyflexon's voting stock. Know All does not have significant influence over Phyflexon. Know All intends to hold the investment for the indefinite future. Date Accounts Debit Credit Jan. 14 Aug. 22: Received a cash dividend of $0.57 per share on the Phyflexon stock. Date Accounts Debit Credit Aug. 22 Dec. 31: Adjusted the Phyflexon investment to its current market value of $54. Date Accounts Debit Credit Dec. 31 Requirement 2. What account(s) and amount(s), if any, would be reported on Know All's income statement for the year ended December 31, 2018? (Use parentheses or a minus sign for a loss.) Know All Investments Income Statement (Partial) For the Year Ended December 31, 2018 Other Income and (Expenses) Jan. 14 Purchased 700 shares of Phyflexon stock, paying $51 per share. The investment represents 4% ownership in Phyflexon's voting stock. Know All does not have significant influence over Phyflexon. Know All intends to hold the investment for the indefinite future. Aug. 22 Received a cash dividend of $0.57 per share on the Phyflexon stock. Dec. 31 Adjusted the Phyflexon investment to its current market value of $54